(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 24.6% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.14%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.5%.
Hyperfine's revenue in 2025 is $10,797,000.On average, 1 Wall Street analysts forecast HYPR's revenue for 2025 to be $1,124,494,124, with the lowest HYPR revenue forecast at $1,124,494,124, and the highest HYPR revenue forecast at $1,124,494,124. On average, 1 Wall Street analysts forecast HYPR's revenue for 2026 to be $1,317,803,387, with the lowest HYPR revenue forecast at $1,317,803,387, and the highest HYPR revenue forecast at $1,317,803,387.
In 2027, HYPR is forecast to generate $1,509,541,029 in revenue, with the lowest revenue forecast at $1,509,541,029 and the highest revenue forecast at $1,509,541,029.